Explore our materials

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Viral Dynamics and the Search for an HIV Cure | Stephen Becker, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Clinical Development of Long-Acting Broadly Neutralizing Monoclonal Antibodies: Lessons Learned Thus Far | Richard Koup, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

How to End the Global HCV Epidemic - the role of injectables | David Thomas, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HAV in a Tertiary Hospital: 2017 Epidemic vs 2009-2016 Period | Andrea Lombardi, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective | Luz Martin-Carbonero, MD, PhD

Massimo Puoti

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective | Massimo Puoti, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

NAFLD in HIV- infected patients | Juan Macías, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Case on HEV | Antonio Rivero-Juarez, PhD

Douglas Dieterich

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Debate: TDF vs. TAF in HBV management | Douglas Dieterich, MD

Mark Nelson

MD, MBBS, FRCP

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Debate: TDF vs. TAF in HBV management | Mark Nelson, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Decrease in HCV Coinfection in Individuals Newly Diagnosed with HIV-1 in Germany, January 2016 - December 2017 | Patrycja Machnowska